KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Silicon Laboratories (SLAB) over the last 17 years, with Q4 2025 value amounting to $341.4 million.

  • Silicon Laboratories' Cash & Equivalents rose 1264.38% to $341.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $341.4 million, marking a year-over-year increase of 1264.38%. This contributed to the annual value of $281.6 million for FY2024, which is 2378.11% up from last year.
  • Per Silicon Laboratories' latest filing, its Cash & Equivalents stood at $341.4 million for Q4 2025, which was up 1264.38% from $314.5 million recorded in Q3 2025.
  • Silicon Laboratories' Cash & Equivalents' 5-year high stood at $1.4 billion during Q4 2021, with a 5-year trough of $159.9 million in Q3 2023.
  • Its 5-year average for Cash & Equivalents is $436.9 million, with a median of $308.8 million in 2021.
  • Per our database at Business Quant, Silicon Laboratories' Cash & Equivalents surged by 49143.25% in 2021 and then plummeted by 7326.98% in 2024.
  • Silicon Laboratories' Cash & Equivalents (Quarter) stood at $1.4 billion in 2021, then crashed by 63.31% to $499.9 million in 2022, then plummeted by 54.49% to $227.5 million in 2023, then rose by 23.78% to $281.6 million in 2024, then rose by 21.23% to $341.4 million in 2025.
  • Its last three reported values are $341.4 million in Q4 2025, $314.5 million for Q3 2025, and $324.9 million during Q2 2025.